BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19118057)

  • 1. Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection.
    Park ES; Do IG; Park CK; Kang WK; Noh JH; Sohn TS; Kim S; Kim MJ; Kim KM
    Clin Cancer Res; 2009 Jan; 15(1):291-8. PubMed ID: 19118057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
    Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
    J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.
    van Beek J; zur Hausen A; Klein Kranenbarg E; van de Velde CJ; Middeldorp JM; van den Brule AJ; Meijer CJ; Bloemena E
    J Clin Oncol; 2004 Feb; 22(4):664-70. PubMed ID: 14966089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma.
    Yamac D; Ayyildiz T; Coşkun U; Akyürek N; Dursun A; Seckin S; Koybasioglu F
    Pathol Res Pract; 2008; 204(8):527-36. PubMed ID: 18462890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma.
    Song HJ; Srivastava A; Lee J; Kim YS; Kim KM; Ki Kang W; Kim M; Kim S; Park CK; Kim S
    Gastroenterology; 2010 Jul; 139(1):84-92.e2. PubMed ID: 20398662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.
    Koriyama C; Akiba S; Itoh T; Kijima Y; Sueyoshi K; Corvalan A; Herrera-Goepfer R; Eizuru Y
    Int J Mol Med; 2002 Nov; 10(5):635-9. PubMed ID: 12373307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
    Denkert C; Winzer KJ; Müller BM; Weichert W; Pest S; Köbel M; Kristiansen G; Reles A; Siegert A; Guski H; Hauptmann S
    Cancer; 2003 Jun; 97(12):2978-87. PubMed ID: 12784332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis.
    Lee JH; Kim SH; Han SH; An JS; Lee ES; Kim YS
    J Gastroenterol Hepatol; 2009 Mar; 24(3):354-65. PubMed ID: 19335785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
    Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
    Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) infection and p53 protein expression in gastric carcinoma.
    Szkaradkiewicz A; Majewski W; Wal M; Czyzak M; Majewski P; Bierła J; Kuch A
    Virus Res; 2006 Jun; 118(1-2):115-9. PubMed ID: 16413625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role and prognostic significance of proapoptotic proteins in Epstein-Barr virus-infected gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Anticancer Res; 2007; 27(2):785-91. PubMed ID: 17465203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
    Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
    Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome.
    Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N
    Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.
    Mrena J; Wiksten JP; Thiel A; Kokkola A; Pohjola L; Lundin J; Nordling S; Ristimäki A; Haglund C
    Clin Cancer Res; 2005 Oct; 11(20):7362-8. PubMed ID: 16243808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
    Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
    Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease.
    Saxena A; Nath Prasad K; Chand Ghoshal U; Krishnani N; Roshan Bhagat M; Husain N
    Scand J Gastroenterol; 2008; 43(6):669-74. PubMed ID: 18569983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.